Vimarsana
Biggest News Aggregation in the World

Page 31 - Research Models News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Research Models. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Research Models Today - Breaking & Trending Today

Rivermont Capital Management LP Buys Shares of 19,565 Charles River Laboratories International, Inc. (NYSE:CRL) - Vimarsana News

Rivermont Capital Management LP Buys Shares of 19,565 Charles River Laboratories International, Inc. (NYSE:CRL)

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

Southpoint Capital Advisors LP Makes New $80.73 Million Investment in Charles River Laboratories International, Inc. (NYSE:CRL) - Vimarsana News

Southpoint Capital Advisors LP Makes New $80.73 Million Investment in Charles River Laboratories International, Inc. (NYSE:CRL)

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Epoch Investment Partners Inc. - Vimarsana News

Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Epoch Investment Partners Inc.

Epoch Investment Partners Inc. cut its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 63.9% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,675 shares of the medical research company’s stock after selling 4,725 shares during the quarter. Epoch […]

Charles River Laboratories International (NYSE:CRL) Downgraded by StockNews.com - Vimarsana News

Charles River Laboratories International (NYSE:CRL) Downgraded by StockNews.com

StockNews.com downgraded shares of Charles River Laboratories International (NYSE:CRL – Free Report) from a buy rating to a hold rating in a research note published on Saturday morning. Other equities research analysts have also issued research reports about the company. Wells Fargo & Company lowered their target price on Charles River Laboratories International from $290.00 […]

BI Asset Management Fondsmaeglerselskab A S Boosts Stake in Charles River Laboratories International, Inc. (NYSE:CRL) - Vimarsana News

BI Asset Management Fondsmaeglerselskab A S Boosts Stake in Charles River Laboratories International, Inc. (NYSE:CRL)

BI Asset Management Fondsmaeglerselskab A S raised its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 136.1% in the first quarter, Holdings Channel.com reports. The fund owned 876 shares of the medical research company’s stock after buying an additional 505 shares during the quarter. BI Asset Management Fondsmaeglerselskab A […]